A Study of Avutometinib (VS-6766) and Defactinib in People with Mesonephric Gynecologic Cancer
Description
This study will test if Avutometinib (VS-6766) in combination with Defactinib is an effective treatment for advanced or recurrent mesonephric gynecologic cancer.